ASX:PAA - PharmAust New cancer treatment available for dogs with Lymphoma

Wednesday, November 6, 2019 9:40 PM +00:00

ASX:PAA - PharmAust New cancer treatment avai...0:0012:43
LIVEQuality1  AudioSubtitleDownloadSpeed1  
PHARMAUST LIMITED
Roger Aston

PharmAust Limited (ASX: PAA) is pleased to announce that its new clinical trial in partnership with U-Vet Werribee Animal Hospital is currently recruiting. The trial will evaluate the drug monepantel, which has shown promising anti-cancer results in vitro, in mice and in previous preliminary investigations in dogs with lymphoma as well as in a Phase I study in humans with cancer.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 2 Dec

    02:00

    Quantify Technology (ASX:QFY) discusses Honeywell MOU & BLAQ partnership

    QUANTIFY TECHNOLOGY HOLDINGS LIMITED
  • 2 Dec

    02:00

    Zelira Therapeutics on its acquisition with Ilera

    ZELIRA THERAPEUTICS LTD
  • 2 Dec

    02:00

    Resolute Mining - The World's First Fully Automated Gold Mine.

    RESOLUTE MINING LIMITED
  • 2 Dec

    02:00

    Powering Smart Hospitals with AI at the Edge

    NVIDIA CORPORATION
  • 2 Dec

    02:00

    The Assay TV: Scott Williamson, Blackstone Minerals

    BLACKSTONE MINERALS LIMITED